HomeGON • FRA
add
Geron Corp
Previous close
€1.40
Day range
€1.37 - €1.37
Year range
€0.92 - €2.28
Market cap
1.07B USD
Avg Volume
4.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 48.02M | 1.01% |
Operating expense | 41.67M | -3.93% |
Net income | -31.14M | -22.85% |
Net profit margin | -64.86 | -21.62% |
Earnings per share | -0.02 | 40.45% |
EBITDA | -10.66M | 46.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 359.80M | -11.50% |
Total assets | 570.54M | -3.91% |
Total liabilities | 346.95M | 10.68% |
Total equity | 223.59M | — |
Shares outstanding | 667.16M | — |
Price to book | 4.11 | — |
Return on assets | -4.74% | — |
Return on capital | -9.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -31.14M | -22.85% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
229
